Momelotinib Bests Danazol in Symptomatic, Anemic Myelofibrosis
Momelotinib proved superior to danazol in patients with symptomatic, anemic myelofibrosis in a phase 3 study.
Myeloproliferative Neoplasms
The Effect of Gender Bias in Surveys of Patients With Myeloproliferative Neoplasm
Gender balance in cancer surveys of patients with myeloproliferative neoplasms was found to have relatively little effect on survey outcomes.
ROCK1/2 May Be Novel Therapeutic Target in Myeloproliferative Neoplasms
Researchers sought to determine whether inhibiting ROCK1/2 when using interferon therapy would be effective in patients with MPNs.
LMNB1 Gene Deletion Associated With Change in Nuclear Structure in Myeloid Neoplasms
Researchers sought to determine whether there is a link in loss of LMNB1 expression with changes in myeloid neoplasms.
Feasibility of Azacitidine in Myelodysplastic/Myeloproliferative Chronic Myelomonocytic Leukemia
A retrospective study sought to determine the response to azacitidine in patients with CMML applying the overlap MDS/MPN response criteria.
Prevalence of Frailty in Patients With MPNs Linked to Subtype
Researchers sought to determine the prevalence of frailty among patients with myeloproliferative neoplasms.
Determining Candidacy of Patients With MF for Allogeneic Stem Cell Transplantation
A team of researchers presented their strategies for choosing patients with myelofibrosis who may be candidates for allogeneic stem cell transplantation and guiding their treatment.
Features and Outcomes in Myelodysplastic Syndrome, Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis
Researchers sought to characterize features and outcomes specific to patients with MDS and MPNs with ring sideroblasts and thrombocytosis.
Higher Symptom Burden More Likely to Improve With MPN Treatment
Analysis of data from 2 clinical trials sought to determine the effect on symptom burden of 2 common therapies for myeloproliferative neoplasms.
CADM1 Tumor Suppressor Gene Identified as Candidate Gene in Myelodysplastic Syndromes With Del(11q)
Researchers sought to determine whether the tumor suppressor gene CADM1 would be a factor influencing MDS with del(11q).
- Loading...
Loading...
Next post in Myelodysplastic Syndromes
Loading... 
Loading...